Russell Investments Group Ltd. Increases Stock Holdings in Pfizer Inc. (NYSE:PFE)
2 Articles
2 Articles
Premenstrual Syndrome Treatment Market to Witness Stunning Growth with Pfizer, Bayer, AbbVie
The latest study released on the Global Premenstrual Syndrome Treatment Market by HTF MI evaluates market size, trend, and forecast to 2031. The Premenstrual Syndrome Treatment market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcom…
Russell Investments Group Ltd. Increases Stock Holdings in Pfizer Inc. (NYSE:PFE)
Russell Investments Group Ltd. grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,798,470 shares of the biopharmaceutical company’s stock after purchasing an additional 73,526 shares during the quarter. Russell Investments Group […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage